Fentanyl Transdermal Patch and Lefamulin: Interaction Details
- Fentanyl Transdermal Patch
- DuragesicAbstralSubsys +3 more
- Lefamulin
- Xenleta
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Fentanyl Transdermal Patch and Lefamulin interaction:
Fentanyl Transdermal Patch
- Duragesic
- Abstral
- Subsys
- Ionsys
- Actiq
- Fentora
What Happens When You Take Fentanyl Transdermal Patch With Lefamulin
What can happen when they are taken together (rated Major)
Increased sensitive exposure and an increased risk of sensitive CYP3A4 substrate-related toxicities associated with cardiac conduction
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
When oral lefamulin is given together with sensitive CYP3A4 substrates, exposure to those substrates may rise, which raises the risk of adverse effects. Patients should be monitored for adverse effects of such agents while they are taking lefamulin oral tablets.
A drug interaction study evaluated oral midazolam, a sensitive substrate, given at the same time as lefamulin oral tablets and also at 2 or 4 hours after the lefamulin dose. Under these conditions, the mean (0 to infinity) of midazolam increased by roughly 200% and the mean by roughly 100%.1
The Fentanyl Transdermal Patch and Lefamulin Interaction, Explained
Fentanyl patches release pain medicine through your skin over several days. Your body breaks fentanyl down mostly using an enzyme called . Lefamulin (Xenleta), an antibiotic for pneumonia, can slow that enzyme down, so fentanyl may build up in your body.
More fentanyl than expected can cause extra sleepiness, slow breathing, dizziness, and heart rhythm changes. This concern is theoretical for the patch, but it is based on a real finding with another drug. Please don't change or remove your patch on your own. Let your pharmacist and doctor know you are taking both. They can watch you closely and adjust your care if needed.
Mechanism: Lefamulin inhibits . Fentanyl is a sensitive CYP3A4 (active drug, not a ), so is expected to raise fentanyl exposure and increase toxicity, including , , and cardiac conduction effects.
- Magnitude: Oral lefamulin raised midazolam about 200% and about 100%. No fentanyl-specific data; evidence is theoretical. The label interaction concerns oral lefamulin.
- Onset: Unspecified. Transdermal fentanyl has a long with a skin depot, so effects may be delayed and prolonged.
- Management: Monitor for adverse effects (sedation, respiratory depression, QT/conduction changes). Individualize dosing as needed and monitor more closely during and after lefamulin therapy.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Fentanyl Transdermal Patch and Lefamulin Interact
The likely mechanism
of -mediated by lefamulin
How to Manage the Fentanyl Transdermal Patch and Lefamulin Interaction
Your care team usually manages this by watching you more closely rather than avoiding the combination automatically. Your fentanyl dose may need to be adjusted and individualized by your care team.
- Keep using your patch and taking lefamulin exactly as prescribed unless told otherwise.
- Tell your pharmacist and prescriber about both medicines.
- Report unusual sleepiness, slow or shallow breathing, confusion, dizziness, fainting, or a racing or irregular heartbeat right away.
- Avoid alcohol and other sedating medicines unless your team approves.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Fentanyl Transdermal Patch or Lefamulin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
1 report from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Prescribing information: XENLETA oral tablets, intravenous injection, lefamulin oral tablets, intravenous injection
A drug interaction study found that when oral midazolam (a sensitive ) was given together with lefamulin oral tablets, and also when it was given 2 or 4 hours after the tablets, mean midazolam and rose by roughly 200% and 100%, respectively.1
Fentanyl Transdermal Patch and Lefamulin: Common Questions
How serious is the Fentanyl Transdermal Patch and Lefamulin interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Fentanyl Transdermal Patch and Lefamulin interaction managed?
Your care team usually manages this by watching you more closely rather than avoiding the combination automatically. Your fentanyl dose may need to be adjusted and individualized by your care team. Keep using your patch and taking lefamulin exactly as prescribed unless told otherwise. Tell your pharmacist and prescriber about both medicines. Report unusual sleepiness, slow or shallow breathing, co… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Fentanyl Transdermal Patch and Lefamulin Interaction
Ask in your own words about taking Fentanyl Transdermal Patch and Lefamulin together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: XENLETA(R) oral tablets, intravenous injection, lefamulin oral tablets, intravenous injection. Nabriva Therapeutics US Inc (per FDA), King of Prussia, PA, 2021. DailyMed
Other Serious Interactions of Fentanyl Transdermal Patch and Lefamulin
Also serious with Fentanyl Transdermal Patch
- IsocarboxazidContraindicated
- LevoketoconazoleContraindicated
- NaltrexoneContraindicated
- PhenelzineContraindicated
Also serious with Lefamulin
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.